Gastrointestinal cytoprotection by PPARγ ligands

PPAR Research

Volumn , Issue , 2010, Pages

  Naito, Yuji ^a   Takagi, Tomohisa ^a   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIGLITAZONE; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA LIGAND; PIOGLITAZONE; ROSIGLITAZONE; TROGLITAZONE; UNCLASSIFIED DRUG;

BARRETT ESOPHAGUS; CARCINOGENESIS; CELL PROLIFERATION; CELL PROTECTION; DIGESTIVE SYSTEM INFLAMMATION; DRUG EFFICACY; ENTERITIS; IMMUNOREGULATION; INFLAMMATION; INSULIN SENSITIVITY; LIPID METABOLISM; NONHUMAN; PROTEIN EXPRESSION; REVIEW; STOMACH MUCOSA INJURY; STOMACH ULCER;

EID: 78349252725     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2010/108632     Document Type: Review

References (66)

1. Mangelsdorf D. J., Thummel C., Beato M., Herrlich P., Schtz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R. M., The nuclear receptor super-family: the second decade Cell 1995 83 6 835 839
2. Sher T., Yi H.-F., McBride O. W., Gonzalez F. J., cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor Biochemistry 1993 32 21 5598 5604
3. Schmidt A., Endo N., Rutledge S. J., Vogel R., Shinar D., Rodan G. A., Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids Molecular Endocrinology 1992 6 10 1634 1641
4. Elbrecht A., Chen Y., Cullinan C. A., Hayes N., Leibowitz M. D., Moller D. E., Berger J., Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors 1 and 2 Biochemical and Biophysical Research Communications 1996 224 2 431 437
5. Fajas L., Auboeuf D., Rasp E., Schoonjans K., Lefebvre A.-M., Saladin R., Najib J., Laville M., Fruchart J.-C., Deeb S., Vidal-Puig A., Flier J., Briggs M. R., Staels B., Vidal H., Auwerx J., The organization, promoter analysis, and expression of the human PPAR gene Journal of Biological Chemistry 1997 272 30 18779 18789
6. Ricote M., Li A. C., Willson T. M., Kelly C. J., Glass C. K., The peroxisome proliferator-activated receptor- is a negative regulator of macrophage activation Nature 1998 391 6662 79 82
7. Jiang C., Ting A. T., Seed B., PPAR- agonists inhibit production of monocyte inflammatory cytokines Nature 1998 391 6662 82 86
8. Auboeuf D., Rieusset J., Fajas L., Vallier P., Frering V., Riou J. P., Staels B., Auwerx J., Laville M., Vidal H., Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor- in humans: no alteration in adipose tissue of obese and NIDDM patients Diabetes 1997 46 8 1319 1327
9. Marx N., Schnbeck U., Lazar M. A., Libby P., Plutzky J., Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells Circulation Research 1998 83 11 1097 1103
10. Mukherjee R., Jow L., Noonan D., McDonnell D. P., Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators Journal of Steroid Biochemistry and Molecular Biology 1994 51 3-4 157 166
11. Al-Taie O. H., Graf T., Illert B., Katzenberger T., Mrk H., Kraus M. R., Barthelmes H. U., Scheurlen M., Seufert J., Differential effects of PPAR activation by the oral antidiabetic agent pioglitazone in Barrett's carcinoma in vitro and in vivo Journal of Gastroenterology 2009 44 9 919 929
12. Konturek P. C., Nikiforuk A., Kania J., Raithel M., Hahn E. G., Mhldorfer S. M., Activation of NF B represents the central event in the neoplastic progression associated with Barrett's esophagus: a possible link to the inflammation and overexpression of COX-2, PPAR and growth factors Digestive Diseases and Sciences 2004 49 7-8 1075 1083
13. Takashima T., Fujiwara Y., Hamaguchi M., Sasaki E., Tominaga K., Watanabe T., Oshitani N., Higuchi K., Arakawa T., Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma Oncology Reports 2005 13 4 601 606
14. Terashita Y., Sasaki H., Haruki N., Nishiwaki T., Ishiguro H., Shibata Y., Kudo J., Konishi S., Kato J., Koyama H., Kimura M., Sato A., Shinoda N., Kuwabara Y., Fujii Y., Decreased peroxisome proliferator-activated receptor gamma gene expression is correlated with poor prognosis in patients with esophageal cancer Japanese Journal of Clinical Oncology 2002 32 7 238 243 (Pubitemid 43102806)
15. Naito Y., Takagi T., Matsuyama K., Yoshida N., Yoshikawa T., Pioglitazone, a specific PPAR- ligand, inhibits aspirin-induced gastric mucosal injury in rats Alimentary Pharmacology and Therapeutics 2001 15 6 865 873
16. Ichikawa H., Naito Y., Takagi T., Tomatsuri N., Yoshida N., Yoshikawa T., A specific peroxisome proliferator-induced receptor- (PPAR- ) ligand, pioglitazone, ameliorates gastric mucosal damage induced by ischemia and reperfusion in rats Redox Report 2002 7 5 343 346
17. Konturek P. C., Brzozowski T., Kania J., Kukharsky V., Bazela K., Kwiecien S., Harsch I., Konturek S. J., Hahn E. G., Pioglitazone, a specific ligand of the peroxisome proliferator-activated receptor gamma reduces gastric mucosal injury induced by ischaemia/reperfusion in rat Scandinavian Journal of Gastroenterology 2003 38 5 468 476
18. Nakajima A., Wada K., Miki H., Kubota N., Nakajima N., Terauchi Y., Ohnishi S., Saubermann L. J., Kadowaki T., Blumberg R. S., Nagai R., Matsuhashi N., Endogenous PPAR mediates anti-inflammatory activity in murine ischemia-reperfusion injury Gastroenterology 2001 120 2 460 469
19. Takagi T., Naito Y., Ichikawa H., Tomatsuri N., Katada K., Isozaki Y., Kuroda M., Kokura S., Yoshida N., Yoshikawa T., A PPAR- ligand, 15-deoxy-12,14-prostaglandin J2, inhibited gastric mucosal injury induced by ischemia-reperfusion in rats Redox Report 2004 9 6 376 381
20. Villegas I., Martin A. R., Toma W., De La Lastra C. A., Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats: role of oxygen free radicals generation European Journal of Pharmacology 2004 505 13 195 203
21. Wada K., Nakajima A., Takahashi H., Yoneda M., Fujisawa N., Ohsawa E., Kadowaki T., Kubota N., Terauchi Y., Matsuhashi N., Saubermann L. J., Nakajima N., Blumberg R. S., Protective effect of endogenous PPAR against acute gastric mucosal lesions associated with ischemia-reperfusion American Journal of Physiology 2004 287 2 G452 G458
22. Lahiri S., Sen T., Palit G., Involvement of glucocorticoid receptor and peroxisome proliferator activated receptor- in pioglitazone mediated chronic gastric ulcer healing in rats European Journal of Pharmacology 2009 609 13 118 125
23. Konturek P. C., Brzozowski T., Kania J., Konturek S. J., Kwiecien S., Pajdo R., Hahn E. G., Pioglitazone, a specific ligand of peroxisome proliferator-activated receptor-gamma, accelerates gastric ulcer healing in rat European Journal of Pharmacology 2003 472 3 213 220
24. Brzozowski T., Konturek P. C., Pajdo R., Kwiecien S., Konturek S., Targosz A., Burnat G., Cieszkowski J., Pawlik W. W., Hahn E. G., Agonist of peroxisome proliferator-activated receptor gamma (PPAR- ): a new compound with potent gastroprotective and ulcer healing properties Inflammopharmacology 2005 13 13 317 330
25. Naito Y., Takagi T., Uchiyama K., Handa O., Tomatsuri N., Imamoto E., Kokura S., Ichikawa H., Yoshida N., Yoshikawa T., Suppression of intestinal ischemia-reperfusion injury by a specific peroxisome proliferator-activated receptor- ligand, pioglitazone, in rats Redox Report 2002 7 5 294 299
26. Cuzzocrea S., Pisano B., Dugo L., Ianaro A., Patel N. S. A., Di Paola R., Genovese T., Chatterjee P. K., Di Rosa M., Caputi A. P., Thiemermann C., Rosiglitazone and 15-deoxy-12,14-prostaglandin J 2, ligands of the peroxisome proliferator-activated receptor- (PPAR- ), reduce ischaemia/reperfusion injury of the gut British Journal of Pharmacology 2003 140 2 366 376
27. Su C. G., Wen X., Bailey S. T., Jiang W., Rangwala S. M., Keilbaugh S. A., Flanigan A., Murthy S., Lazar M. A., Wu G. D., A novel therapy for colitis utilizing PPAR- ligands to inhibit the epithelial inflammatory response Journal of Clinical Investigation 1999 104 4 383 389
28. Saubermann L. J., Nakajima A., Wada K., Zhao S., Terauchi Y., Kadowaki T., Aburatani H., Matsuhashi N., Nagai R., Blumberg R. S., Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis Inflammatory Bowel Diseases 2002 8 5 330 339
29. Takagi T., Naito Y., Tomatsuri N., Handa O., Ichikawa H., Yoshida N., Yoshikawa T., Pioglitazone, a PPAR- ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF- B-cytokine cascade Redox Report 2002 7 5 283 289
30. Schaefer K. L., Denevich S., Ma C., Cooley S. R., Nakajima A., Wada K., Schlezinger J., Sherr D., Saubermann L. J., Intestinal antiinflammatory effects of thiazolidenedione peroxisome proliferator-activated receptor- ligands on T helper type 1 chemokine regulation include nontranscriptional control mechanisms Inflammatory Bowel Diseases 2005 11 3 244 252
31. Bassaganya-Riera J., Reynolds K., Martino-Catt S., Cui Y., Hennighausen L., Gonzalez F., Rohrer J., Benninghoff A. U., Hontecillas R., Activation of PPAR and by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease Gastroenterology 2004 127 3 777 791
32. Desreumaux P., Dubuquoy L., Nutten S., Peuchmaur M., Englaro W., Schoonjans K., Derijard B., Desvergne B., Wahli W., Chambon P., Leibowitz M. D., Colombel J.-F., Auwerx J., Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor (PPAR ) heterodimer: a basis for new therapeutic strategies Journal of Experimental Medicine 2001 193 7 827 838
33. Snchez-Hidalgo M., Martn A. R., Villegas I., Alarcn de la Lastra C., Rosiglitazone, a PPAR ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats European Journal of Pharmacology 2007 562 3 247 258
34. Rousseaux C., Lefebvre B., Dubuquoy L., Lefebvre P., Romano O., Auwerx J., Metzger D., Wahli W., Desvergne B., Naccari G. C., Chavatte P., Farce A., Bulois P., Cortot A., Colombel J. F., Desreumaux P., Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator- activated receptor- Journal of Experimental Medicine 2005 201 8 1205 1215
35. Lytle C., Tod T. J., Vo K. T., Lee J. W., Atkinson R. D., Straus D. S., The peroxisome proliferator-activated receptor ligand rosiglitazone delays the onset of inflammatory bowel disease in mice with interleukin 10 deficiency Inflammatory Bowel Diseases 2005 11 3 231 243
36. Sugawara K., Olson T. S., Moskaluk C. A., Stevens B. K., Hoang S., Kozaiwa K., Cominelli F., Ley K. F., McDuffie M., Linkage to peroxisome proliferator-activated receptor- in SAMP1/YitFc mice and in human Crohn's disease Gastroenterology 2005 128 2 351 360
37. Marshall B. J., Warren J. R., Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration Lancet 1984 1 8390 1311 1314
38. International Agency for Research on Cancer WHO, Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 1994 61 1 241
39. Slomiany B. L., Slomiany A., Suppression of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by peroxisome proliferator-activated receptor activation IUBMB Life 2002 53 6 303 308
40. Haruna H., Shimizu T., Ohtsuka Y., Yarita Y., Fujii T., Kudo T., Yamashiro Y., Expression of COX-1, COX-2, and PPAR- in the gastric mucosa of children with Helicobacter pylori infection Pediatrics International 2008 50 1 1 6
41. Konturek P. C., Kania J., Kukharsky V., Raithel M., Ocker M., Rembiasz K., Hahn E. G., Konturek S. J., Implication of peroxisome proliferator-activated receptor and proinflammatory cytokines in gastric carcinogenesis: link to Helicobacter pylori -infection Journal of Pharmacological Sciences 2004 96 2 134 143
42. Cheon C. W., Kim D. H., Kim D. H., Cho Y. H., Kim J. H., Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells World Journal of Gastroenterology 2009 15 3 310 320
43. Lu J., Imamura K., Nomura S., Mafune K.-I., Nakajima A., Kadowaki T., Kubota N., Terauchi Y., Ishii G., Ochiai A., Esumi H., Kaminishi M., Chemopreventive effect of peroxisome proliferator-activated receptor on gastric carcinogenesis in mice Cancer Research 2005 65 11 4769 4774
44. Nagamine M., Okumura T., Tanno S., Sawamukai M., Motomura W., Nobuhiko T., Kohgo Y., PPAR ligand-induced apoptosis through a p53-dependent mechanism in human gastric cancer cells Cancer Science 2003 94 4 338 343
45. Deeb S. S., Fajas L., Nemoto M., Pihlajamki J., Mykknen L., Kuusisto J., Laakso M., Fujimoto W., Auwerx J., A Pro12Ala substitution in PPAR 2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity Nature Genetics 1998 20 3 284 287
46. Landi S., Moreno V., Gioia-Patricola L., Guino E., Navarro M., De Oca J., Capella G., Canzian F., Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor, NFKB1, and peroxisome proliferator-activated receptor with colorectal cancer Cancer Research 2003 63 13 3560 3566
47. Altshuler D., Hirschhorn J. N., Klannemark M., Lindgren C. M., Vohl M.-C., Nemesh J., Lane C. R., Schaffner S. F., Bolk S., Brewer C., Tuomi T., Gaudet D., Hudson T. J., Daly M., Groop L., Lander E. S., The common PPAR Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes Nature Genetics 2000 26 1 76 80
48. Chae S. J., Kim J. J., Choi Y. M., Kim J. M., Cho Y. M., Moon S. Y., Peroxisome proliferator-activated receptor- and its coactivator-1 gene polymorphisms in korean women with polycystic ovary syndrome Gynecologic and Obstetric Investigation 2010 70 1 1 7
49. Oh S.-H., Park S.-M., Park J.-S., Jang A.-S., Lee Y.-M., Uh S.-T., Hoon Kim Y., Choi I.-S., Kim M.-K., Park B. L., Shin H.-D., Park C.-S., Association analysis of peroxisome proliferator-activated receptors gamma gene polymorphisms with asprin hypersensitivity in asthmatics Allergy, Asthma and Immunology Research 2009 1 1 30 35
50. Hwang K. R., Choi Y. M., Kim J. M., Association of peroxisome proliferator-activated receptor- 2 Pro12Ala polymorphism with advanced-stage endometriosis. American Journal of Reproductive Immunology. In press
51. Liao S.-Y., Zeng Z.-R., Leung W. K., Zhou S.-Z., Chen B., Sung J. J. Y., Hu P.-J., Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism, Helicobacter pylori infection and non-cardia gastric carcinoma in Chinese Alimentary Pharmacology and Therapeutics 2006 23 2 289 294
52. Prasad K. N., Saxena A., Ghoshal U. C., Bhagat M. R., Krishnani N., Analysis of Pro12Ala PPAR gamma polymorphism and Helicobacter pylori infection in gastric adenocarcinoma and peptic ulcer disease Annals of Oncology 2008 19 7 1299 1303
53. Tahara T., Arisawa T., Shibata T., Nakamura M., Wang F., Maruyama N., Kamiya Y., Nakamura M., Fujita H., Nagasaka M., Iwata M., Takahama K., Watanabe M., Hirata I., Nakano H., Influence of peroxisome proliferator-activated receptor (PPAR) Plo12Ala polymorphism as a shared risk marker for both gastric cancer and impaired fasting glucose (IFG) in Japanese Digestive Diseases and Sciences 2008 53 3 614 621
54. Dubuquoy L., Jansson E. A., Deeb S., Rakotobe S., Karoui M., Colombel J.-F., Auwerx J., Pettersson S., Desreumaux P., Impaired expression of peroxisome proliferator-activated receptor in ulcerative colitis Gastroenterology 2003 124 5 1265 1276
55. Chang S. E., Dong S. H., Seung H. L., Chang H. P., Yong W. C., Lee J., Joon S. H., Attenuation of colonic inflammation by PPAR in intestinal epithelial cells: effect on toll-like receptor pathway Digestive Diseases and Sciences 2006 51 4 693 697
56. Baregamian N., Mourot J. M., Ballard A. R., Evers B. M., Chung D. H., PPAR- agonist protects against intestinal injury during necrotizing enterocolitis Biochemical and Biophysical Research Communications 2009 379 2 423 427
57. Xavier R. J., Podolsky D. K., Unravelling the pathogenesis of inflammatory bowel disease Nature 2007 448 7152 427 434
58. Katayama K., Wada K., Nakajima A., Mizuguchi H., Hayakawa T., Nakagawa S., Kadowaki T., Nagai R., Kamisaki Y., Blumberg R. S., Mayumi T., A novel PPAR gene therapy to control inflammation associated with inflammatory bowel disease in a murine model Gastroenterology 2003 124 5 1315 1324
59. Klotz L., Dani I., Edenhofer F., Nolden L., Evert B., Paul B., Kolanus W., Klockgether T., Knolle P., Diehl L., Peroxisome proliferator-activated receptor control of dendritic cell function contributes to development of CD4+ T cell anergy Journal of Immunology 2007 178 4 2122 2131
60. Hontecillas R., Bassaganya-Riera J., Peroxisome proliferator-activated receptor is required for regulatory CD4+ T cell-mediated protection against colitis Journal of Immunology 2007 178 5 2940 2949
61. Lewis J. D., Lichtenstein G. R., Stein R. B., Deren J. J., Judge T. A., Fogt F., Furth E. E., Demissie E. J., Hurd L. B., Su C. G., Keilbaugh S. A., Lazar M. A., Wu G. D., An open-label trial of the PPAR ligand rosiglitazone for active ulcerative colitis American Journal of Gastroenterology 2001 96 12 3323 3328
62. DuBois R. N., Gupta R., Brockman J., Reddy B. S., Krakow S. L., Lazar M. A., The nuclear eicosanoid receptor, PPAR, is aberrantly expressed in colonic cancers Carcinogenesis 1998 19 1 49 53
63. Sarraf P., Mueller E., Jones D., King F. J., DeAngelo D. J., Partridge J. B., Holden S. A., Chen L. B., Singer S., Fletcher C., Spiegelman B. M., Differentiation and reversal of malignant changes in colon cancer through PPAR Nature Medicine 1998 4 9 1046 1052
64. Yang W.-L., Frucht H., Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells Carcinogenesis 2001 22 9 1379 1383
65. Osawa E., Nakajima A., Wada K., Ishimine S., Fujisawa N., Kawamori T., Matsuhashi N., Kadowaki T., Ochiai M., Sekihara H., Nakagama H., Peroxisome proliferator-activated receptor ligands suppress colon carcinogenesis induced by azoxymethane in mice Gastroenterology 2003 124 2 361 367
66. Lefebvre A.-M., Chen I., Desreumaux P., Najib J., Fruchart J.-C., Geboes K., Briggs M., Heyman R., Auwerx J., Activation of the peroxisome proliferator-activated receptor promotes the development of colon tumors in C57BL/6J-APC(Min)/+ mice Nature Medicine 1998 4 9 1053 1057